Introduction
============

Phylogenetically diverse microorganisms such as bacteria, viruses or protozoans commonly pose as "pathogens." They have the capacity to survive in the host tissue, adapt to and suppress the host innate immune responses, thus constantly challenging human health and welfare. The normal microbial flora that inhabits specific regions in the host organism is essential for the proper functioning of the host. In contrast, pathogens elicit specific unnatural responses in the host system. Over the years, the field of infection biology has thus generated much interest, especially with the current emergence of various multi-drug resistant strains. The infection cycle of a pathogen comprises mainly of three stages, namely introduction of the pathogen into the host cell or tissue, establishment of the pathogen within the host and dissemination within the host. Despite continuous improvements in the techniques developed to identify and elucidate infection patterns, there is a pressing demand for more efficient advancements to interpret the molecular cues during infection. Mass spectrometry based proteomics, through the years, has been instrumental in deciphering the molecular mechanisms underlying host--pathogen interactions ([@B77]). Development of high-resolution instruments and improvements in experimental techniques has helped expand the scope of infection biology.

The delicate balance that exists between the host immune responses and the pathogen can be tipped toward the latter by the co-existence of multiple microbial species capable of colonizing the same host niche. Bacteria have been identified in a wide range of symbiotic associations such as pathogenic, mutualistic or as commensals. The state of "natural selection" enforces interspecies specific interactions that differ significantly from the behavior of the individual species. Bacterial co-cultures or mixed populations find numerous benefits (1) they are commonly employed in the biotechnology industry such as in waste water treatment ([@B66]), biogas plants ([@B27]), production of vitamin C ([@B37]); (2) they form an important part of the human gut microbiota ([@B52]). Adversely, symbiotic interactions can also be unfavorable, resulting in host invasion and damage ([@B11]; [@B28]). Thus systematic analysis of bacteria in co-culture conditions is essential to obtain an understanding of microbial behavior under conditions of infection. Routine strategies employed by pathogens to defeat host immune responses generally include adherence to host cell surfaces, followed by invasion and subsequent production and secretion of enterotoxins along with exhibiting host molecular mimicry mechanisms ([@B79]). Protein secretion systems are thus pivotal in infection ([@B68]). Targeting any one of these systems could help curb transmission of the disease or elimination of the pathogen. The following sections in this review describe the implications of various post-translational modifications (PTMs) on bacterial virulence and the proteomics technologies available to investigate such events along with the associated technical challenges.

Post-Translational Modifications
================================

Protein PTMs are known to play diverse roles in the cellular milieu. Bacterial virulence is orchestrated by a multitude of PTMs. Some of the most common PTMs critical for the infection process are reviewed here.

Phosphorylation
---------------

Phosphorylation is a well-characterized and ubiquitous PTM that is crucial for most functions occurring in a bacterial cell. Apart from regulating metabolic pathways, phosphorylation has also been seen to be involved in various virulence mechanisms. The existence of Hanks-type Ser/Thr kinases in bacteria has generated a huge interest in the field of infection biology. Pathogenic strains such as *Streptococcus* spp., *Pseudomonas aeruginosa*, *Mycobacteria*, *Yersinia* spp., to name a few, employ Ser/Thr kinase-mediated host--pathogen interactions to mediate diverse cellular networks required for adhesion to and invasion of the host. While the exact mechanism of infection is not yet well understood, the mode of infection has been speculated to follow three basic modes: (1) phosphorylation of host proteins, (2) disruption of host defense mechanisms due to kinase activity, and lastly (3) essential role of Ser/Thr kinases by unrealized processes ([@B8]). The global phosphoproteome of a number of pathogenic bacteria such as *Corynebacterium glutamicum* ([@B6]), *Campylobacter jejuni* ([@B71]), *Klebsiella pneumoniae* ([@B34]), *Mycobacterium tuberculosis* ([@B51]), *Streptomyces coelicolor* ([@B48]), to name a few, have been analyzed. Changes that occur in the host phosphoproteome upon bacterial infection have also been investigated ([@B59]; [@B60]). Dynamics of the bacterial phosphoproteome at the time of infection and post infection would be an interesting avenue to embark upon.

Secretion systems play a vital role during pathogenesis in a large number of bacteria. *Yersinia enterocolitica* and other species encode for a protein kinase A, YopO, which is secreted into the host via the type III secretion system. This kinase helps resist phagocytosis by macrophages via disruption of host cytoskeletal elements ([@B22]; [@B16]). This kinase was also reported to phosphorylate actin and otubain, resulting in inhibition of phagocytosis ([@B23]). Mutation of the kinase domain has been shown to reduce lethality during infection ([@B14]; [@B73]). Similarly, Stk1 from *Staphylococcus aureus* has been shown to phosphorylate numerous host substrates involved in cell cycle signaling or apoptotic pathways ([@B40]). SteC of *Salmonella enterica* serovar Typhimurium, like YopO, induces reorganization of actin filaments in the host on infection ([@B46]). Host immune cell responses depend on the proper functioning of the NF-κB pathway. *Legionella pneumophila* LegK acts as an inflammatory agent and interferes with the NF-κB pathway ([@B15]). Likewise, protein kinases NleH1 and NleH2 from enteropathogenic *Escherichia coli* work by inhibiting the transcription factor, NF-κB ([@B55]). Phosphorylation of the central core of type II fatty acid synthase (FASH) in *Mycobacterium tuberculosis*, catalyzed by the kinase KasB, governs the physiopathology of tuberculosis ([@B70]). Apart from phosphorylation by Ser/Thr Hanks-type kinases, bacterial two-component systems involving phosphorylation on histidine-aspartate residues (TCS) form a major adaptive mechanism in pathogenic strains. For example, CovRS (the control of virulence regulator/sensor kinase) in the human pathogen group A *Streptococcus* is fundamental for virulence ([@B21]). Interestingly, cysteine protein phosphorylation events are also reported to mediate bacterial virulence. The SarA/MarA staphylococcal accessary regulator A, part of the family of global transcriptional regulators (MgrA), is phosphorylated/dephosphorylated by the *Staphylococcus aureus* kinase/phosphatase pair Stk1-Stp1 and speculated to play a crucial role in shifting the intracellular redox balance, contributing to virulence ([@B63]).

Cognate to kinase activity is the activity of phosphatases, making phosphorylation a reversible and tightly regulated PTM. In many organisms, protein phosphatases act as essential virulence determinants, thus playing a central role in infection and dissemination. YopH tyrosine phosphatase from *Yersinia* is involved in the dephosphorylation of the focal adhesion complexes and essential for antiphagocytosis ([@B49]). SptP tyrosine phosphatase of *Salmonella typhimurium* was observed to be required for virulence in murine models ([@B24]). The phosphothreonine lyase protein, OspF, from *Shigella flexneri* irreversibly phosphorylates members of the MAPK and ERK pathway, subsequently affecting the innate immune system ([@B53]). Dephosphorylation of tyrosine kinases such as the BY-kinase Wzc-ca from *E. coli* K12 by Wzb causes increased capsular polysaccharide formation which can further act as a poor immunogen ([@B72]; [@B18]).

Acylation
---------

Acetylation can be used as a mechanism to modulate phosphorylation-based signaling. *Yersinia* species use a serine/threonine acetyltransferase, YopJ, to interfere with host MAPK kinase signaling by acetylating serine and threonine residues in the activation loop thereby preventing phosphorylation-dependent activation ([@B42]). YopJ homologs are widely distributed in both mammal and plant pathogens suggesting that inhibition of host kinases by serine/threonine acetylation could be a common strategy for bacterial pathogens ([@B32]). Lysine acetylation and succinylation have in recent years been shown to be abundant modifications in bacteria, and there are some indications that they could be important for bacterial pathogenesis. In *E. coli*, the transcription factor RcsB that controls colanic acid capsule synthesis, is acetylated on lysine thereby reducing its DNA binding activity ([@B65]). A global study indicated that lysine acetylation is involved in regulation of cell wall fatty acids synthesis in *M. tuberculosis*, which in turn is implicated in pathogenicity ([@B35]). In addition, a lysine deacetylase (MRA_1161) mutant exhibits a defect in biofilm formation ([@B35]). KasA, a protein involved in biofilm formation, is modified by another type of acylation namely lysine succinylation. Further, a number of proteins involved in antibiotic resistance are succinylated ([@B76]). With only few functional studies, it is still unclear to what extent lysine acetylation and succinylation contribute to bacterial virulence.

Ubiquitination
--------------

Ubiquitination is an important PTM in Eukarya and regulates several processes including key cell defense systems. Ubiquitin is a small polypeptide (78 amino acids) that can be covalently linked to primarily lysine. Ubiquitination requires the activities of an E1 activating enzyme, an E2 conjugating enzyme and an E3 ligase ([@B3]). Ubiquitin contains seven lysines and can itself be ubiquitinated leading to formation of polyubiquitin chains with various linkages that in turn dictates biological function ([@B3]). Bacterial pathogens have developed several ways of targeting the host ubiquitin system including the use of Eukaryotic-like and novel E3 ligases as well as de-ubiquitinating enzymes. The *S. flexneri* E3 ligase IpaH9.8 reduces the NF-κB-mediated inflammatory response by polyubiquitination of NEMO, a protein involved in NF-κB activation, thereby targeting it for degradation ([@B4]). Additionally, IpaH9.8 appears to modulate gene expression via ubiquitination of the splicing factor U2AF^35^ ([@B47]; [@B61]). In *S. enterica* infection, ubiquitinated protein aggregates are formed near the *Salmonella*-containing vacuole which targets it for autophagic degradation. This is countered by SseL, a deubiquitinase, that deubiquitinates the protein aggregates ([@B39]). The pathogens can also use the host ubiquitination system to modify their own proteins. To control the timing of effector protein-mediated functions, *S. enterica* SopE, that targets RHO-GTPases leading to membrane ruffling, is ubiquitinated and degraded earlier than the protein SptP that prevents membrane ruffling after invasion ([@B30]). Another *S. enterica* effector protein, the phosphatase SopB, can be mono-ubiquitinated at six positions and this in turn modulates its cellular location and enzyme activity ([@B29]).

AMPylation
----------

AMPylation is the covalent attachment of AMP to a threonine or tyrosine residue. *Vibrio parahaemolyticus* effector VopS uses ATP to covalently modify Rho-GTPases with AMP on threonine. This is turn affects its interaction with downstream signaling proteins leading to inhibition of actin assembly ([@B78]). To exploit host cell vesicle transport, *L. pneumophila* SidM activates the small GTPase Rab1 by AMPylation on a tyrosine, and when Rab1 is no longer needed, it is de-AMPylated by SidD, and subsequently targeted for degradation by polyubiquitination ([@B45]). Host GTPases are also targeted by another novel, reversible PTM, namely phosphocholination. *L. pneumophila* effectors AnkX and Lpg0696 phosphocholinate and de-phosphocholinate Rab1 and Rab35, respectively ([@B43]; [@B64]).

Alkylation
----------

Protein alkylation is the addition of alkyl groups on specific amino acids, notably methyl on arginine and lysine (methylation) and the lipids farnesyl or geranylgeranyl isoprenyl on cysteine (prenylation). Histone proteins are regulated by lysine methylation, and this is also a target for bacterial pathogens. The *Bacillus anthracis* protein BaSET trimethylates histone H1 on lysine and thereby reduces activation of NF-κB response elements ([@B41]). Prenylation confers hydrophobicity to its substrate proteins and target them to membranes. This is employed by *L. pneumophila* to assure correct cellular localization of its effector AnkB. Host-mediated farnesylation of AnkB, targets it to the cytosolic face of the *Legionella*-containing vacuole and this in turn is essential for its function ([@B50]).

Eliminylation
-------------

*Shigella flexneri* effector protein OspF, a phosphothreonine lyase, interferes with host signaling by irreversibly dephosphorylating MAP kinases. In this PTM termed eliminylation, not only the phosphate but also the hydroxyl group of threonine is removed, thereby preventing any future phosphorylation. It irreversibly inactivates the kinase ([@B33]).

Glycosylation
-------------

Protein glycosylation is now a well-established modification in bacteria. O-linked glycosylation of flagellar proteins has been linked to virulence in pathogenic bacteria. In the opportunistic pathogen *Burkholderia cenocepacia*, glycosylation of the flagellar protein FliC reduces binding to the host TLR5 receptor, thereby weakening the immune response. Additionally, a non-glycosylated FliC mutant exhibits a defect in biofilm formation ([@B19]). *Helicobacter pylori* flagellar proteins are also glycosylated, and this is essential for virulence ([@B56]). In a systematic study of *H. pylori* glycoproteins, 26 proteins with diverse roles in pathogenesis were identified, arguably indicating a broader array of mechanisms for glycosylation-based virulence ([@B10]).

Potential of Proteomics
=======================

Assessment of host--pathogen interactions is beneficial from a surveillance and diagnostic perspective. Pursuing the proteomic signatures of pathogenic bacteria during infection states could reveal dynamic changes that occur in the proteome or PTM proteome, which are often induced due to the selection pressure occurring during the interaction with the host. High-resolution mass spectrometry based proteomics has the ability to bridge the gap between genomics and the physiological mechanisms of behavior ([@B12]). Global and quantitative analysis of the pathogen proteome provides an in depth understanding of the molecular events that are differentially regulated during the onset of infection. Dynamic changes occurring at the proteome level, quantitative post-translational modification analysis are some of the basic and widely used applications of the shotgun proteomics technology. The high-throughput "omics" technology also allows for identification of macromolecular components important for specific cell-to-cell communications ([@B9]), for monitoring metabolic shifts and revealing metabolic pathways involved and/or activated during specific stages of infection. The conventional shot-gun proteomics or the bottom-up approach involves protein extraction from the organism of interest followed by digestion with a suitable endoprotease and subsequent analysis by LC-MS/MS. Entire bacterial proteomes and factors that play a key role in certain virulence pathways can be identified and analyzed conveniently by employing this approach ([@B67]; [@B1]). Conversely, top-down approaches that involve the analysis of intact proteins have also been adopted to characterize bacterial proteomes ([@B2]). Additionally, while challenging, top-down proteomics can be employed to study PTMs such as phosphorylation, acetylation, etc, occurring in the bacterial proteome as well as the host proteome upon infection ([@B26]; [@B80]).

Microbial proteomics additionally aids in detection of biomarkers which could possibly act as targets for drug based therapy ([@B17]). Proteomics studies conducted on the effects of drug dosage are also crucial for acquiring information about the real-time *in vivo* scenario, thus assisting in the development of antimicrobial drugs. Targeted proteomics is also a powerful method for focusing on a specific subset of proteins involved in infection and resistance mechanisms, allowing for mechanistic questions to be answered.

Current Technology
==================

A limited number of non-proteomics based methodologies are currently employed for the investigation of population dynamics of binary mixed cultures ([@B28]), namely, Fluorescence *In Situ* Hybridization (FISH; [@B54]), Real-Time PCR ([@B20]), Flow Cytometry ([@B44]) and Terminal Restriction Fragment Length Polymorphism (T-RFLP; [@B58]). Metaproteome analysis of mixed cultures using 2-DE followed by LC-ESI-MS has been utilized to identify diverse microbial communities in the environment ([@B7]; [@B28]). High-resolution mass spectrometry based approaches are routinely employed to study bacterial infection models or bacterial co-cultures. Global subcellular protein profiling has been applied to reveal subcellular distributions of proteins, subsequently used to reconstruct functional networks and to identify new targets responsible for pathogenicity ([@B38]). *De novo* sequencing has been applied for peptide/protein identification when the DNA sequence coverage of a particular organism has been unavailable or incomplete ([@B74]). Centrifugation followed by detergent solubilization ([@B13]); ImmunoMagnetic Separation (IMS) using anti-IgG-coated Dynabeads^TM^ in combination with antisera ([@B69]); or Fluorescence-Activated Cell Sorting (FACS; [@B5]) based approaches are routinely used for separation of bacterial cells from host cells. Pulse-chase experiments using ^35^S-labeled methionine or cysteine can also be employed to monitor changes occurring at the level of protein synthesis or protein turn-over ([@B57]). Quantification of proteome dynamics post infection can be done by label free approaches \[for example, [@B36] identified 2125 phosphopeptides and quantified 253 and 344 up-regulated phosphorylation events from PRRSV-infected pulmonary alveolar macrophages 12 and 36 h postinoculation respectively by employing label free approaches ([@B36])\] or by other label based relative quantitation methods such as iTRAQ (isobaric tagging for relative and absolute quantitation) or SILAC (stable isotope labeling with amino acids in cell culture; [@B62]). In the paper by [@B62], a total of 1286 proteins were identified from murine macrophages during *M. tuberculosis* infection, of which 463 were identified by both SILAC and iTRAQ labeling strategies. Targeted proteomics, that forms a part of the newer generation proteomics approaches, can also be applied to study specific changes occurring in the host or bacterial cell by applying multiple reaction monitoring mass spectrometry (MRM-MS). [@B31] employ multiple reaction monitoring to understand the dynamics of virulence factors from the Gram-positive bacterium *Streptococcus pyogenes*. Similarly, [@B25] use selected reaction monitoring mass spectrometry (SRM-MS) to decipher the *S. pyogenes* proteome. Mass-spectrometry based imaging techniques form a fresh avenue of approach for studying differences in microbial communities ([@B75]).

Technical Challenges
====================

In the field of infection biology, the characterization of microbes existing as interacting communities is extremely challenging but essential ([@B28]). Genome is a static entity, while the proteome is dynamic, creating a higher order of complexity in whole proteome analysis in comparison to the genome. The presence of PTMs further increases the functional diversity of an organism's proteome. Furthermore, only a fraction of a given organism's proteome is modified at any given time point, making it harder to detect or quantify certain events. Limitations with respect to instrumentation can also decrease the mass range of detection, hence losing out on critical biological information. Another major limiting factor is the absence of a complete genome sequence for many relevant bacterial species in complex environmental samples. As a consequence, limitations in the analysis of protein modifications could occur mainly due to the partial sequence coverage. When investigating bacterial proteomes under conditions of infection, extra care must be taken to ensure that the ratio of abundance of the bacterial to eukaryal proteins is not disproportional, as the bacterial proteome can easily be drowned in the noise of the highly abundant eukaryal proteins. Furthermore, the complete recoverability of the low number of bacterial cells under such conditions is difficult. This is a challenge for the PTM analysis, as generally a high amount of protein is required for enrichment of modified peptides. Additionally, mammalian-based infection studies are limited by ethical constraints, and a delicate balance must be struck to gain mechanistic understanding in a true *in vivo* setup.

Perspectives
============

Developments in experimental methodologies and instrumentation have made it possible to efficiently investigate host--pathogen interactions. However, there is still a necessity for further advances in instrumentation, technology and improvements in data processivity to be able to (a) obtain a complete or sufficiently high coverage of the pathogen proteome starting with low input material; (b) conveniently identify and differentiate between organism-specific proteomes to be able to monitor the species-specific changes occurring; and (c) routinely monitor alterations occurring at the post-translation level to reveal the pathways relevant for drug targeting. Proteomics based mass-spectrometry is a powerful tool that helps obtain a functional understanding of microbial co-operativity, interaction, evolution, physiological changes and cellular functioning. Quantitative proteomic profiling of host--pathogen interactions and discovery mode proteomics, in combination with bioinformatics, have been shown as an effective approach to illuminate key factors intrinsic to host invasion and disease propagation. Additionally, data-dependent analysis or targeted approaches show a high degree of promise and are now being applied for biomarker discovery and clinical applications. The potential for definite target selection and validation should be further exploited to reveal basic solutions to important biological issues. Furthermore, proteomics analysis of PTMs from the bacterial perspective would be an interesting avenue to venture into. Apart from a few global phosphoproteome analyses, currently there are not many reports on other post-translationally modified pathogenic bacterial proteomes. Resolving some of the above-described technical challenges could aid in unraveling physiological pathways affected by PTMs that help in virulence.
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